Just nine months after a $55 million series B fundraising round, Billiontoone Inc. delivered an oversubscribed series C of $125 million. Demand for the company’s Unity prenatal test, which can assess fetal risk for common recessive conditions and aneuploidies using one maternal blood sample, tripled over the last year. Read More
Publicly traded companies in the life sciences face a number of sources of litigation, including lawsuits over alleged securities fraud, and a new report by Dechert LLP highlights a diminishing number of such lawsuits across the U.S. economy. However, the proportion of such lawsuits directed at drug and device makers has not diminished, making clear that companies in the life sciences must tread carefully when disclosing information such as the status of products in development for fear that a perceived misrepresentation could spark expensive and time-consuming litigation. Read More
A research team from the Grenoble Institute for Neuroscience (GIN) recently discovered a blood biomarker capable of detecting the onset of Parkinson's disease (PD) from a very early stage. This discovery represents the findings of a multi-model, translational study published in the Journal of Clinical Investigation. Read More
Following a traumatic birth experience with her second child, Baymatob Ltd. Founder and engineer Sarah McDonald felt she had a moral obligation to do something to help women, and she developed a wearable device that uses artificial intelligence (AI) to identify mothers during labor who are at high risk of developing abnormal postpartum hemorrhage (PPH) well before giving birth. Read More
The U.S. Preventive Services Task Force (USPSTF) has decided to consider the merits of screening for obstructive sleep apnea (OSA), a condition thought to contribute significantly to the onset of heart disease. Even though five years have passed since the task force considered the merits of screening for asymptomatic patients, USPSTF indicated that there is still insufficient evidence to support the proposition, citing an evidence gap that if filled could prove tremendously useful to makers of devices that diagnose and treat the condition. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Fresnenius, Ivenix, Labcorp, Medidata, Mainz Biomed. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Edwards. Read More
